Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05638334
What this trial is testing

Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
Institut de Recherches Internationales Servier 3
Early research (Phase 1)Study completedNCT04153565
What this trial is testing

Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

Who this might be right for
Mesothelioma
Merck Sharp & Dohme LLC 19
Early research (Phase 1)Study completedNCT01475006
What this trial is testing

AMG 595 First-in-Human in Recurrent Gliomas

Who this might be right for
Advanced Malignant GliomaAnaplastic AstrocytomasGlioblastoma Multiforme
Amgen 32
Early research (Phase 1)Ended earlyNCT02192567
What this trial is testing

Open Label Study of DS-5573a

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 19
Testing effectiveness (Phase 2)Looking for participantsNCT06581432
What this trial is testing

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Who this might be right for
Solid Tumours
Boehringer Ingelheim 588
Early research (Phase 1)Study completedNCT03852511
What this trial is testing

First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody)

Who this might be right for
Metastatic CancerEpithelial Tumor
Akamis Bio 28
Testing effectiveness (Phase 2)Looking for participantsNCT05039632
What this trial is testing

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+1 more
M.D. Anderson Cancer Center 40
Early research (Phase 1)Looking for participantsNCT07338838
What this trial is testing

To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 66
Not applicableLooking for participantsNCT06404528
What this trial is testing

Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours

Who this might be right for
Solid Tumors, Adult
Wuxi People's Hospital 300
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Early research (Phase 1)WithdrawnNCT01941849
What this trial is testing

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

Who this might be right for
PhaeochromocytomaParaganglioma
University College, London
Early research (Phase 1)Study completedNCT03009214
What this trial is testing

A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours

Who this might be right for
Malignant Solid Tumor
amcure GmbH 55
Early research (Phase 1)Study completedNCT00721266
What this trial is testing

A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 102
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Looking for participantsNCT07111546
What this trial is testing

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Who this might be right for
Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd 140
Early research (Phase 1)Study completedNCT04483505
What this trial is testing

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

Who this might be right for
Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast
Fundacion CRIS de Investigación para Vencer el Cáncer 9
Early research (Phase 1)Active Not RecruitingNCT05327946
What this trial is testing

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated

Who this might be right for
Solid Tumors
Boehringer Ingelheim 42
Early research (Phase 1)Not Yet RecruitingNCT07612488
What this trial is testing

CS231295 in Patients With Advanced Solid Tumors

Who this might be right for
Advance Solid TumorsAdvanced Malignant Solid Tumors
ThalassaX Therapeutics United States Ltd 42
Testing effectiveness (Phase 2)Study completedNCT00651703
What this trial is testing

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG 21
Early research (Phase 1)Study completedNCT02144051
What this trial is testing

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

Who this might be right for
Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
AstraZeneca 32
Next Page